Status:

RECRUITING

Effects of a Nursing-led Communication Using Mobile Health Information in Breast Cancer Patients Undergoing Concurrent Chemotherapy

Lead Sponsor:

National Defense Medical Center, Taiwan

Conditions:

Breast Cancer Early Stage Breast Cancer (Stage 1-3)

Eligibility:

FEMALE

18+ years

Phase:

NA

Brief Summary

Breast cancer is the most common malignant tumor among women. Side effects from initial chemotherapy include sleep disorders, anxiety, depression, and reduced quality of life. Mental health distress i...

Detailed Description

The objective of this study is to explore the effects of a nursing-led communication support program using mobile health information on physical and mental state in breast cancer patients undergoing i...

Eligibility Criteria

Inclusion

  • breast cancer initial chemotherapy

Exclusion

  • Patients whose cancer has recurred without undergoing the first course of chemotherapy

Key Trial Info

Start Date :

November 1 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

May 1 2025

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT06949046

Start Date

November 1 2024

End Date

May 1 2025

Last Update

April 29 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Tri-Service General Hospital

Taipei, Taiwan